White Papers¶
This section hosts Migibio's technical white papers — in-depth documents on veterinary POCT technology and the case for quantitative point-of-care diagnostics.
White papers are the deepest form of content on this site: they synthesize the technology, the evidence, and the clinical argument into a single citable document.
Available White Papers¶
| Title | Focus |
|---|---|
| Veterinary POCT: The FICT Advantage | Why quantitative, instrument-read POCT outperforms qualitative strips and complements the laboratory |
White Paper Topics¶
Upcoming and in-progress white papers cover:
- The economics of in-clinic testing — total cost per result for POCT vs send-out laboratory, including clinician time and repeat-visit cost.
- Early kidney disease detection — the clinical case for SDMA-based screening in geriatric patients.
- Acute-phase proteins in practice — CRP and SAA as triage and treatment-monitoring tools.
Why We Publish White Papers¶
White papers serve three audiences:
- Veterinarians evaluating whether to adopt quantitative POCT — the clinical and economic argument.
- Distributors and OEM partners evaluating the technology for their market.
- Procurement and practice managers building a business case for in-clinic instrumentation.
Reading the Evidence Chain¶
Each white paper links back to the primary evidence:
- Analytical Performance — the method-validation data.
- Comparative Studies — head-to-head method comparisons.
- Data Hub — the structured reference data.
FAQ¶
Are white papers peer-reviewed? Migibio white papers are reviewed by the R&D Quality Committee (see the Editorial & Review Policy) but are manufacturer publications, not independent peer-reviewed journal articles.
Can I cite a white paper in a procurement document? Yes — cite the page URL and the revision date shown at the bottom of the page.
How do white papers differ from the knowledge base? The knowledge base explains how to use products; white papers argue why the technology matters, with the evidence chain to support it.
Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.
Reviewed by: Migibio R&D Quality Committee
Last updated: 2026-08-13
Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.